Brief: Kancera Q4 Oper Loss Widens To SEK 12.9 Mln

Novakand Pharma AB

19/02/2021 07:41

Feb 19 (Reuters) - Kancera AB  KANC.ST :
    * INTERIM REPORT FOR FOURTH QUARTER 2020, 1 JANUARY - 31
DECEMBER
2020
    * NET SALES FOR PERIOD (JANUARY TO DECEMBER) AMOUNTED TO SEK
0,1
MILLION (3,2 MILLION), OF WHICH Q4 CONTRIBUTED SEK 0 MILLION (0
MILLION).
    * OPERATING PROFIT FOR PERIOD AMOUNTED TO SEK -46,5 MILLION
(-35,6
MILLION), OF WHICH Q4 CONTRIBUTED SEK -12,9 MILLION (-7,6
MILLION).

Source text for Eikon:  ID:nMFN97Jzgf 
Further company coverage:  KANC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))